Envalior and SECARA Advance PCR Caprolactam for PA6

Envalior and SECARA Collaborate on Recycled PA6 Materials

On August 25, Envalior signed a memorandum of understanding with SECARA to test and validate pathways for incorporating high-quality post-consumer-recycled content into technical material grades. The initial focus is PCR-derived caprolactam for PA6, supporting development of recycled-content solutions while maintaining the requirements of technical materials. The collaboration combines Envalior’s materials expertise with SECARA’s catalytic depolymerization process to assess practical pathways for integrating recycled feedstock into material grades relevant to demanding industrial applications.

Focus on Automotive Material Compliance

The results are expected to be particularly relevant to automotive OEMs and Tier 1 suppliers seeking scalable material solutions as regulatory requirements evolve in Europe. The work is aligned with the European Commission’s recently adopted End-of-Life Vehicles Regulation, which increases the importance of incorporating recycled content into automotive materials. By testing PCR-derived caprolactam for PA6 through SECARA’s catalytic depolymerization pathway, the companies aim to evaluate a potential route toward high-quality recycled feedstock that can support technical material applications and future compliance needs.

Frequently Asked Questions

What is the focus of the Envalior and SECARA collaboration?
The collaboration focuses on testing and validating pathways to incorporate high-quality post-consumer-recycled content into technical material grades, initially using PCR-derived caprolactam for PA6. The work is based on SECARA’s catalytic depolymerization process and is intended to assess scalable material solutions for demanding applications. Its results are expected to be particularly relevant to automotive OEMs and Tier 1 suppliers as regulatory requirements increase the need for recycled content in vehicle materials and components across the European market.